Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Today’s NR

<< Previous

Bullboard Posts

Next >>

Comment by HCallahann44on Aug 06, 2021 9:45am

246 Views

Post# 33662873

RE:Today’s NR

Thanks KWS---always appreciate your input. But WHEN will it change? Had I put the money I put here into SAVA at the same time....I would be on a beach somewhere. I know its like saying if I had only picked the correct Powerball number....but its still extremely frustrating... Some are saying SAVA will run to thousands per share...maybe its still not too late there?

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program